Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
153 Leser
Artikel bewerten:
(1)

LSEB Creative Corp Announces Application to Uplist to the OTCQB Marketplace

Finanznachrichten News

TORONTO, ON / ACCESSWIRE / October 30, 2024 / LSEB Creative Corp. (OTC PINK:LSEB) (the "Company"), a visionary new entrant in the fashion sector, is pleased to announce that the Company has filed an application to have its common shares uplisted from the Pink Open Market (OTC Pink) to the OTCQB (Over-the-Counter Quotation Bureau).

This advancement will mark a pivotal step forward as companies listed on the OTCQB marketplace are required to go through more rigorous reporting requirements. Given the Company is currently an SEC reporting issuer, this advancement aligns seamlessly with the OTCQB marketplace requirements. Such proactive measures signify a natural progression for our Company. This heightened regulatory compliance will be especially valuable as LSEB embarks on further domestic and international expansion, providing an additional layer of assurance for both existing and potential investors.

The upgrade process to OTCQB necessitates adherence to specific criteria to include: maintaining current reporting status, undergoing annual verification and certification, meeting a $0.01 bid test, non-bankruptcy status, having at least 50 beneficial shareholders, and a public float in excess of 10% of the total shares outstanding. The Company anticipates the application process to take four to eight weeks.

"The purpose of uplisting to OTCQB is to broaden the Company's shareholder base and enhance the Company's visibility and transparency within the investment community, notably to institutional investors," stated Lauren Bentley, the Company's CEO. "We are confident that uplisting will significantly improve our access to capital and create more dynamic and efficient trading opportunities."

The OTCQB is a U.S. trading platform operated by the OTC Markets Group and is the premier venture marketplace for entrepreneurial and developing U.S. and international companies that are committed to providing a high-quality trading and information experience for their investors. The OTCQB provides key benefits for investors with efficient market standards, transparency, and visibility of companies on the OTCQB market. To be eligible, companies must meet high financial standards, be current in their financial reporting, follow best practice corporate governance, have a professional third-party sponsor introduction, demonstrate compliance with U.S. securities laws, and undergo an annual verification and management certification process.

For More Information See: OTCQB Eligibility Requirements https://www.otcmarkets.com/corporate-services/otcqx-otcqb

About LSEB Creative Corp.
LSEB Creative Corp (OTC PINK:LSEB) is a visionary new entrant in the fashion sector, dedicated to crafting timeless elegance and offering impeccable craftsmanship through its flagship brand, Lauren Bentley Swimwear. The Company sets the standard for sophistication and innovation in swimwear fashion, with a commitment to excellence and creativity.

Certain statements in this document that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of LSEB Creative Corp. to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to: (i) the Company's ability to obtain sufficient capital or a strategic business arrangement to fund its current operational or expansion plans; (ii) the Company's ability to build and maintain the management and human resources and infrastructure necessary to support the anticipated growth of its business; and (iii) competitive factors and developments beyond the Company's control.

For more information, please contact:
LSEB Creative Corp.
Lauren Bentley, CEO
info@lsebcreative.com
laurenbentleyswim.com
Instagram: @laurenbentleyswim

Contact Information
Jordan Starkman
CFO
jstarkman@lsebcreative.com
647-328-8267

SOURCE: LSEB Creative Corp.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.